DNA Methylation-based Diagnosis and Treatment of Breast Cancer

被引：0

作者：

Peng, Xintong ^{[1
]}

Zheng, Jingfan ^{[1
]}

Liu, Tianzi ^{[1
]}

Zhou, Ziwen ^{[1
]}

Song, Chen ^{[1
]}

Zhang, Danyan ^{[1
]}

Zhang, Xinlong ^{[1
]}

Huang, Yan ^{[2
]}

机构：

[1] Affiliated Weifang Med Univ, Sch Clin Med, Weifang, Peoples R China

[2] Weifang Med Univ, Dept Oncol, Affiliated Hosp, Weifang, Peoples R China

来源：

CURRENT CANCER DRUG TARGETS | 2025年 / 25卷 / 01期

关键词：

Epigenetics; DNA methylation; breast cancer; triple-negative breast cancer; prognosis; treatment; PROMOTER METHYLATION; TUMOR-SUPPRESSOR; BIOMARKERS; METASTASIS; EXPRESSION; PROGNOSIS; EPIGENOME; MARKERS; BRCA1; RISK;

D O I：

10.2174/0115680096278978240204162353

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

DNA methylation is a key epigenetic modifier involved in tumor formation, invasion, and metastasis. The development of breast cancer is a complex process, and many studies have now confirmed the involvement of DNA methylation in breast cancer. Moreover, the number of genes identified as aberrantly methylated in breast cancer is rapidly increasing, and the accumulation of epigenetic alterations becomes a chronic factor in the development of breast cancer. The combined effects of external environmental factors and the internal tumor microenvironment promote epigenetic alterations that drive tumorigenesis. This article focuses on the relevance of DNA methylation to breast cancer, describing the role of detecting DNA methylation in the early diagnosis, prediction, progression, metastasis, treatment, and prognosis of breast cancer, as well as recent advances. The reversibility of DNA methylation is utilized to target specific methylation aberrant promoters as well as related enzymes, from early prevention to late targeted therapy, to understand the journey of DNA methylation in breast cancer with a more comprehensive perspective. Meanwhile, methylation inhibitors in combination with other therapies have a wide range of prospects, providing hope to drug-resistant breast cancer patients.

引用

页码：26 / 37

页数：12

共 117 条

[1] PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients [J].

Absmaier, Magdalena ;

Napieralski, Rudolf ;

Schuster, Tibor ;

Aubele, Michaela ;

Walch, Axel ;

Magdolen, Viktor ;

Dorn, Julia ;

Gross, Eva ;

Harbeck, Nadia ;

Noske, Aurelia ;

Kiechle, Marion ;

Schmitt, Manfred .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (03) :755-767

[2] Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis [J].

Aceto, Nicola ;

Bardia, Aditya ;

Miyamoto, David T. ;

Donaldson, Maria C. ;

Wittner, Ben S. ;

Spencer, Joel A. ;

Yu, Min ;

Pely, Adam ;

Engstrom, Amanda ;

Zhu, Huili ;

Brannigan, Brian W. ;

Kapur, Ravi ;

Stott, Shannon L. ;

Shioda, Toshi ;

Ramaswamy, Sridhar ;

Ting, David T. ;

Lin, Charles P. ;

Toner, Mehmet ;

Haber, Daniel A. ;

Maheswaran, Shyamala .

CELL, 2014, 158 (05) :1110-1122

[3] Curcumin induces re-expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines [J].

Al-Yousef, Nujoud ;

Shinwari, Zakia ;

Al-Shahrani, Bushra ;

Al-Showimi, Maram ;

Al-Moghrabi, Nisreen .

ONCOLOGY REPORTS, 2020, 43 (03) :827-838

[4] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].

Albain, K. ;

Anderson, S. ;

Arriagada, R. ;

Barlow, W. ;

Bergh, J. ;

Bliss, J. ;

Buyse, M. ;

Cameron, D. ;

Carrasco, E. ;

Clarke, M. ;

Correa, C. ;

Coates, A. ;

Collins, R. ;

Costantino, J. ;

Cutter, D. ;

Cuzick, J. ;

Darby, S. ;

Davidson, N. ;

Davies, C. ;

Davies, K. ;

Delmestri, A. ;

Di Leo, A. ;

Dowsett, M. ;

Elphinstone, P. ;

Evans, V. ;

Ewertz, M. ;

Gelber, R. ;

Gettins, L. ;

Geyer, C. ;

Goldhirsch, A. ;

Godwin, J. ;

Gray, R. ;

Gregory, C. ;

Hayes, D. ;

Hill, C. ;

Ingle, J. ;

Jakesz, R. ;

James, S. ;

Kaufmann, M. ;

Kerr, A. ;

MacKinnon, E. ;

McGale, P. ;

McHugh, T. ;

Norton, L. ;

Ohashi, Y. ;

Paik, S. ;

Pan, H. C. ;

Perez, E. ;

Peto, R. ;

Piccart, M. .

LANCET, 2012, 379 (9814) :432-444

[5] Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice [J].

Ambrosone, Christine B. ;

Higgins, Michael J. .

CANCER RESEARCH, 2020, 80 (22) :4871-4877

[6] Global DNA demethylation as an epigenetic marker of human brain metastases [J].

Barciszewska, Anna-Maria .

BIOSCIENCE REPORTS, 2018, 38

[7] Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer [J].

Basree, Mustafa M. ;

Shinde, Neelam ;

Koivisto, Christopher ;

Cuitino, Maria ;

Kladney, Raleigh ;

Zhang, Jianying ;

Stephens, Julie ;

Palettas, Marilly ;

Zhang, Allen ;

Kim, Hee Kyung ;

Acero-Bedoya, Santiago ;

Trimboli, Anthony ;

Stover, Daniel G. ;

Ludwig, Thomas ;

Ganju, Ramesh ;

Weng, Daniel ;

Shields, Peter ;

Freudenheim, Jo ;

Leone, Gustavo W. ;

Sizemore, Gina M. ;

Majumder, Sarmila ;

Ramaswamy, Bhuvaneswari .

BREAST CANCER RESEARCH, 2019, 21 (1) :80

[8] Pterostilbene leads to DNMT3B-mediated DNA methylation and silencing of OCT1-targeted oncogenes in breast cancer cells [J].

Beetch, Megan ;

Boycott, Cayla ;

Harandi-Zadeh, Sadaf ;

Yang, Tony ;

Martin, Benjamin J. E. ;

Dixon-McDougall, Thomas ;

Ren, Kevin ;

Gacad, Allison ;

Dupuis, John H. ;

Ullmer, Melissa ;

Lubecka, Katarzyna ;

Yada, Rickey Y. ;

Brown, Carolyn J. ;

Howe, LeAnn J. ;

Stefanska, Barbara .

JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2021, 98

[9] Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models [J].

Buocikova, Verona ;

Longhin, Eleonora Marta ;

Pilalis, Eleftherios ;

Mastrokalou, Chara ;

Miklikova, Svetlana ;

Cihova, Marina ;

Poturnayova, Alexandra ;

Mackova, Katarina ;

Babelova, Andrea ;

Trnkova, Lenka ;

El Yamani, Naouale ;

Zheng, Congying ;

Rios-Mondragon, Ivan ;

Labudova, Martina ;

Csaderova, Lucia ;

Kuracinova, Kristina Mikus ;

Makovicky, Peter ;

Kucerova, Lucia ;

Matuskova, Miroslava ;

Cimpan, Mihaela Roxana ;

Dusinska, Maria ;

Babal, Pavel ;

Chatziioannou, Aristotelis ;

Gabelova, Alena ;

Runden-Pran, Elise ;

Smolkova, Bozena .

BIOMEDICINE & PHARMACOTHERAPY, 2022, 147

[10] Hypomethylating Agent Azacitidine Is Effective in Treating Brain Metastasis Triple-Negative Breast Cancer Through Regulation of DNA Methylation of Keratin 18 Gene [J].

Butler, Christopher ;

Sprowls, Samuel ;

Szalai, Gabor ;

Arsiwala, Tasneem ;

Saralkar, Pushkar ;

Straight, Benjamin ;

Hatcher, Shea ;

Tyree, Evan ;

Yost, Michael ;

Kohler, William J. ;

Wolff, Benjamin ;

Putnam, Emily ;

Lockman, Paul ;

Liu, Tuoen .

TRANSLATIONAL ONCOLOGY, 2020, 13 (06)

← 1 2 3 4 5 6 7 8 9 10 →